Immunai is a biotechnology company specializing in immune cell data analysis for drug development. It offers target identification, preclinical assessment, and clinical trial data analysis using multiomic datasets, immune cell databases, machine learning, and functional genomics. The company serves biopharmaceutical firms and academic research institutions involved in immunology and oncology.